WebApr 13, 2024 · The goal is to find out which aspects of a clinical trial may make it more difficult for patients to take part or see it through. ... (NCT number): NCT05811858. Contacts. Layout table for location contacts; Contact: Michael B Gill: 415-900-4227: [email protected]: Sponsors and Collaborators. WebApproved IDE Studies CMS Medicare Medicare Coverage Related to Investigational Device Exemption (IDE) Studies Approved IDE Studies Approved IDE Studies The following IDE studies have met CMS’ standards for coverage. Studies with the Category A are approved for coverage of routine services only.
NCT05126277 Novartis - Novartis Recruiting Clinical Trials
WebApr 12, 2024 · Step 1 Preliminary phase : collection and assessment of ultrasonic images to visualize dental and periodontal tissues and structures in order to manually perform periodontal measurements and generate data required for the Artificial Intelligence module training Step 2 : Performance Evaluation : assessment of the ultrasonic probe … WebThe NCT Number, also called the ClinicalTrials.gov Identifier, is assigned after the protocol information has been Released (submitted) by the Responsible Party and passed review by ClinicalTrials.gov staff. At that time an e-mail notification containing the NCT Number is sent. The record, including its NCT Number, will typically be available on ClinicalTrials.gov … crwsnm0005
Approved IDE Studies CMS
WebApr 11, 2024 · Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies. WebJun 18, 2024 · ClinicalTrials.gov Identifier: NCT04931342 Recruitment Status : Recruiting First Posted : June 18, 2024 Last Update Posted : April 6, 2024 See Contacts and Locations View this study on Beta.ClinicalTrials.gov Sponsor: Hoffmann-La Roche Collaborators: GOG Foundation European Network of Gynaecological Oncological Trial Groups (ENGOT) WebOct 20, 2024 · This clinical trial evaluates the safety, efficacy, and biomarker levels of FDA-approved drug disulfiram in the treatment of adult subjects hospitalized with moderate COVID-19. Disulfiram may limit the hyperinflammatory response associated with COVID-19 and reduce the risk of progression to severe illness. bulk add users to microsoft 365 group